Skip to main content
SpringerLink
Log in

State of the Art in the Propagation of Circulating Tumor Cells

  • Chapter
  • First Online:
Circulating Tumor Cells

Part of the book series: Current Cancer Research ((CUCR))

  • 361 Accesses

Abstract

Circulating tumor cells (CTCs) are a group of cells that travel through the circulatory system of a cancer patient, sowing distant sites and forming the seeds for metastatic nodules. Given the unique role of CTCs, the study of this cell population could enable significant strides in understanding metastasis. The clinical importance of CTCs for predicting overall survival has been routinely demonstrated. Recently, advancements in culturing and expanding viable CTCs ex vivo made in the last two decades have further enabled researchers to properly interrogate this new frontier of metastatic research. Expansion of CTCs through in vitro cultures and in vivo CTC-derived xenograft models (CDXs) has resulted in groundbreaking findings significantly improving the rather simplistic models of metastasis previously used. In this chapter, we will focus on advancements made toward isolating and culturing CTCs both in a tissue culture plate and through the formation of CDX models. We will highlight two eras of CTC culture: one focused on growing viable epithelial cells and the other focused on modeling CTC heterogeneity. Next, we will explore methods for generating in vivo CTC-derived xenograft models. Comparing CDX models against CTC culture platforms, we will highlight the advantages and disadvantages of each method and where these models fit within the spectrum of metastasis models. Finally, we will preview how CTC expansion may play a crucial role in the era of personalized medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ashworth, T.R. A Case of Cancer in Which Cells Similar to Those in the Tumours Were Seen in the Blood after Death. Australasian Medical Journal 1869, 146–147.

    Google Scholar 

  2. Johnson, P.; Burchill, S.; Selby, P. The Molecular Detection of Circulating Tumour Cells. Brit J Cancer 1995, 72, 268–276, doi:https://doi.org/10.1038/bjc.1995.324.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Racila, E.; Euhus, D.; Weiss, A.J.; Rao, C.; McConnell, J.; Terstappen, L.W.M.M.; Uhr, J.W. Detection and Characterization of Carcinoma Cells in the Blood. Proc National Acad Sci 1998, 95, 4589–4594, doi:https://doi.org/10.1073/pnas.95.8.4589.

    Article  CAS  Google Scholar 

  4. Xiao, J.; Pohlmann, P.R.; Isaacs, C.; Weinberg, B.A.; He, A.R.; Schlegel, R.; Agarwal, S. Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis. Biomed 2021, 9, 1111, doi:https://doi.org/10.3390/biomedicines9091111.

    Article  CAS  Google Scholar 

  5. Bono, J.S. de; Scher, H.I.; Montgomery, R.B.; Parker, C.; Miller, M.C.; Tissing, H.; Doyle, G.V.; Terstappen, L.W.W.M.; Pienta, K.J.; Raghavan, D. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res 2008, 14, 6302–6309, doi:https://doi.org/10.1158/1078-0432.ccr-08-0872.

    Article  PubMed  Google Scholar 

  6. Pantel, K.; Denève, E.; Nocca, D.; Coffy, A.; Vendrell, J.-P.; Maudelonde, T.; Riethdorf, S.; Alix-Panabières, C. Circulating Epithelial Cells in Patients with Benign Colon Diseases. Clin Chem 2012, 58, 936–940, doi:https://doi.org/10.1373/clinchem.2011.175570.

    Article  CAS  PubMed  Google Scholar 

  7. Goldkorn, A.; Ely, B.; Quinn, D.I.; Tangen, C.M.; Fink, L.M.; Xu, T.; Twardowski, P.; Veldhuizen, P.J.V.; Agarwal, N.; Carducci, M.A.; et al. Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol 2014, 32, 1136–1142, doi:https://doi.org/10.1200/jco.2013.51.7417.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Garrel, R.; Mazel, M.; Perriard, F.; Vinches, M.; Cayrefourcq, L.; Guigay, J.; Digue, L.; Aubry, K.; Alfonsi, M.; Delord, J.-P.; et al. Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study. Clin Chem 2019, 65, 1267–1275, doi:https://doi.org/10.1373/clinchem.2019.305904.

    Article  CAS  PubMed  Google Scholar 

  9. Dawood, S.; Broglio, K.; Valero, V.; Reuben, J.; Handy, B.; Islam, R.; Jackson, S.; Hortobagyi, G.N.; Fritsche, H.; Cristofanilli, M. Circulating Tumor Cells in Metastatic Breast Cancer. Cancer 2008, 113, 2422–2430, doi:https://doi.org/10.1002/cncr.23852.

    Article  PubMed  Google Scholar 

  10. Yu, M.; Bardia, A.; Wittner, B.S.; Stott, S.L.; Smas, M.E.; Ting, D.T.; Isakoff, S.J.; Ciciliano, J.C.; Wells, M.N.; Shah, A.M.; et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition. Science 2013, 339, 580–584, doi:https://doi.org/10.1126/science.1228522.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yu, M.; Bardia, A.; Aceto, N.; Bersani, F.; Madden, M.W.; Donaldson, M.C.; Desai, R.; Zhu, H.; Comaills, V.; Zheng, Z.; et al. Ex Vivo Culture of Circulating Breast Tumor Cells for Individualized Testing of Drug Susceptibility. Science 2014, 345, 216–220, doi:https://doi.org/10.1126/science.1253533.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Stott, S.L.; Lee, R.J.; Nagrath, S.; Yu, M.; Miyamoto, D.T.; Ulkus, L.; Inserra, E.J.; Ulman, M.; Springer, S.; Nakamura, Z.; et al. Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer. Sci Transl Med 2010, 2, 25ra23-25ra23, doi:https://doi.org/10.1126/scitranslmed.3000403.

    Article  CAS  Google Scholar 

  13. Yu, M.; Ting, D.T.; Stott, S.L.; Wittner, B.S.; Ozsolak, F.; Paul, S.; Ciciliano, J.C.; Smas, M.E.; Winokur, D.; Gilman, A.J.; et al. RNA Sequencing of Pancreatic Circulating Tumour Cells Implicates WNT Signalling in Metastasis. Nature 2012, 487, 510–513, doi:https://doi.org/10.1038/nature11217.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Goldkorn, A.; Ely, B.; Tangen, C.M.; Tai, Y.; Xu, T.; Li, H.; Twardowski, P.; Veldhuizen, P.J.V.; Agarwal, N.; Carducci, M.A.; et al. Circulating Tumor Cell Telomerase Activity as a Prognostic Marker for Overall Survival in SWOG 0421: A Phase III Metastatic Castration Resistant Prostate Cancer Trial. Int J Cancer 2015, 136, 1856–1862, doi:https://doi.org/10.1002/ijc.29212.

    Article  CAS  PubMed  Google Scholar 

  15. Aceto, N.; Bardia, A.; Miyamoto, D.T.; Donaldson, M.C.; Wittner, B.S.; Spencer, J.A.; Yu, M.; Pely, A.; Engstrom, A.; Zhu, H.; et al. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis. Cell 2014, 158, 1110–1122, doi:https://doi.org/10.1016/j.cell.2014.07.013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lin, Z.; Luo, G.; Du, W.; Kong, T.; Liu, C.; Liu, Z. Recent Advances in Microfluidic Platforms Applied in Cancer Metastasis: Circulating Tumor Cells’ (CTCs) Isolation and Tumor-On-A-Chip. Small 2020, 16, 1903899, doi:https://doi.org/10.1002/smll.201903899.

    Article  CAS  Google Scholar 

  17. Balic, M.; Williams, A.; Lin, H.; Datar, R.; Cote, R.J. Circulating Tumor Cells: From Bench to Bedside. Annu Rev Med 2013, 64, 31–44, doi:https://doi.org/10.1146/annurev-med-050311-163404.

    Article  CAS  PubMed  Google Scholar 

  18. Agarwal, A.; Balic, M.; El-Ashry, D.; Cote, R.J. Circulating Tumor Cells. Cancer J 2018, 24, 70–77, doi:https://doi.org/10.1097/ppo.0000000000000310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zhang, L.; Ridgway, L.D.; Wetzel, M.D.; Ngo, J.; Yin, W.; Kumar, D.; Goodman, J.C.; Groves, M.D.; Marchetti, D. The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis. Sci Transl Med 2013, 5, 180ra48-180ra48, doi:https://doi.org/10.1126/scitranslmed.3005109.

    Article  CAS  Google Scholar 

  20. Tayoun, T.; Faugeroux, V.; Oulhen, M.; Aberlenc, A.; Pawlikowska, P.; Farace, F. CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs). Cells 2019, 8, 1145, doi:https://doi.org/10.3390/cells8101145.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Baccelli, I.; Schneeweiss, A.; Riethdorf, S.; Stenzinger, A.; Schillert, A.; Vogel, V.; Klein, C.; Saini, M.; Bauerle, T.; Wallwiener, M.; et al. Identification of a Population of Blood Circulating Tumor Cells from Breast Cancer Patients That Initiates Metastasis in a Xenograft Assay. Nat Biotechnol 2013, 31, 539–44, doi:https://doi.org/10.1038/nbt.2576.

    Article  CAS  PubMed  Google Scholar 

  22. Sheng, W.; Ogunwobi, O.O.; Chen, T.; Zhang, J.; George, T.J.; Liu, C.; Fan, Z.H. Capture, Release and Culture of Circulating Tumor Cells from Pancreatic Cancer Patients Using an Enhanced Mixing Chip. Lab Chip 2013, 14, 89–98, doi:https://doi.org/10.1039/c3lc51017d.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhang, Z.; Shiratsuchi, H.; Lin, J.; Chen, G.; Reddy, R.M.; Azizi, E.; Fouladdel, S.; Chang, A.C.; Lin, L.; Jiang, H.; et al. Expansion of CTCs from Early Stage Lung Cancer Patients Using a Microfluidic Co-Culture Model. Oncotarget 2014, 5, 12383–12397, doi:https://doi.org/10.18632/oncotarget.2592.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Gao, D.; Vela, I.; Sboner, A.; Iaquinta, P.J.; Karthaus, W.R.; Gopalan, A.; Dowling, C.; Wanjala, J.N.; Undvall, E.A.; Arora, V.K.; et al. Organoid Cultures Derived from Patients with Advanced Prostate Cancer. Cell 2014, 159, 176–187, doi:https://doi.org/10.1016/j.cell.2014.08.016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Cayrefourcq, L.; Mazard, T.; Joosse, S.; Solassol, J.; Ramos, J.; Assenat, E.; Schumacher, U.; Costes, V.; Maudelonde, T.; Pantel, K.; et al. Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells. Cancer Res 2015, 75, 892–901, doi:https://doi.org/10.1158/0008-5472.can-14-2613.

    Article  CAS  PubMed  Google Scholar 

  26. So, E.C.; Sallin, M.A.; Zhang, X.; Chan, S.L.; Sahni, L.; Schulze, D.H.; Davila, E.; Strome, S.E.; Jain, A. A High Throughput Method for Enrichment of Natural Killer Cells and Lymphocytes and Assessment of in Vitro Cytotoxicity. J Immunol Methods 2013, 394, 40–48, doi:https://doi.org/10.1016/j.jim.2013.05.001.

    Article  CAS  PubMed  Google Scholar 

  27. Risbridger, G.P.; Toivanen, R.; Taylor, R.A. Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models. Csh Perspect Med 2018, 8, a030536, doi:https://doi.org/10.1101/cshperspect.a030536.

    Article  CAS  Google Scholar 

  28. Fabbri, F.; Carloni, S.; Zoli, W.; Ulivi, P.; Gallerani, G.; Fici, P.; Chiadini, E.; Passardi, A.; Frassineti, G.L.; Ragazzini, A.; et al. Detection and Recovery of Circulating Colon Cancer Cells Using a Dielectrophoresis-Based Device: KRAS Mutation Status in Pure CTCs. Cancer Lett 2013, 335, 225–231, doi:https://doi.org/10.1016/j.canlet.2013.02.015.

    Article  CAS  PubMed  Google Scholar 

  29. Zhang, Y.; Men, Y.; Wang, J.; Xing, P.; Zhao, J.; Li, J.; Xu, D.; Hui, Z.; Cui, W. Epithelial Circulating Tumor Cells with a Heterogeneous Phenotype Are Associated with Metastasis in NSCLC. J Cancer Res Clin 2021, 1–10, doi:https://doi.org/10.1007/s00432-021-03681-9.

  30. Ao, Z.; Parasido, E.; Rawal, S.; Williams, A.; Schlegel, R.; Liu, S.; Albanese, C.; Cote, R.J.; Agarwal, A.; Datar, R.H. Thermoresponsive Release of Viable Microfiltrated Circulating Tumor Cells (CTCs) for Precision Medicine Applications. Lab Chip 2015, 15, 4277–4282, doi:https://doi.org/10.1039/c5lc01024a.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Khoo, B.L.; Lee, S.C.; Kumar, P.; Tan, T.Z.; Warkiani, M.E.; Ow, S.GW.; Nandi, S.; Lim, C.T.; Thiery, J.P. Short-Term Expansion of Breast Circulating Cancer Cells Predicts Response to Anti-Cancer Therapy. Oncotarget 2015, 6, 15578–15593, doi:https://doi.org/10.18632/oncotarget.3903.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kolostova, K.; Spicka, J.; Matkowski, R.; Bobek, V. Isolation, Primary Culture, Morphological and Molecular Characterization of Circulating Tumor Cells in Gynecological Cancers. Am J Transl Res 2015, 7, 1203–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Lin, H.K.; Zheng, S.; Williams, A.J.; Balic, M.; Groshen, S.; Scher, H.I.; Fleisher, M.; Stadler, W.; Datar, R.H.; Tai, Y.-C.; et al. Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells. Clin Cancer Res 2010, 16, 5011–5018, doi:https://doi.org/10.1158/1078-0432.ccr-10-1105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Szczerba, B.M.; Castro-Giner, F.; Vetter, M.; Krol, I.; Gkountela, S.; Landin, J.; Scheidmann, M.C.; Donato, C.; Scherrer, R.; Singer, J.; et al. Neutrophils Escort Circulating Tumour Cells to Enable Cell Cycle Progression. Nature 2019, 566, 553–557, doi:https://doi.org/10.1038/s41586-019-0915-y.

    Article  CAS  PubMed  Google Scholar 

  35. Salmaninejad, A.; Valilou, S.F.; Soltani, A.; Ahmadi, S.; Abarghan, Y.J.; Rosengren, R.J.; Sahebkar, A. Tumor-Associated Macrophages: Role in Cancer Development and Therapeutic Implications. Cell Oncol 2019, 42, 591–608, doi:https://doi.org/10.1007/s13402-019-00453-z.

    Article  Google Scholar 

  36. Xiao, J.; McGill, J.R.; Stanton, K.; Kassner, J.D.; Choudhury, S.; Schlegel, R.; Sauna, Z.E.; Pohlmann, P.R.; Agarwal, S. Efficient Propagation of Circulating Tumor Cells: A First Step for Probing Tumor Metastasis. Cancers 2020, 12, 2784, doi:https://doi.org/10.3390/cancers12102784.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Carmona-Ule, N.; González-Conde, M.; Abuín, C.; Cueva, J.F.; Palacios, P.; López-López, R.; Costa, C.; Dávila-Ibáñez, A.B. Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications. Cancers 2021, 13, 2668, doi:https://doi.org/10.3390/cancers13112668.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Micalizzi, D.S.; Maheswaran, S.; Haber, D.A. A Conduit to Metastasis: Circulating Tumor Cell Biology. Gene Dev 2017, 31, 1827–1840, doi:https://doi.org/10.1101/gad.305805.117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kallergi, G.; Konstantinidis, G.; Markomanolaki, H.; Papadaki, M.A.; Mavroudis, D.; Stournaras, C.; Georgoulias, V.; Agelaki, S. Apoptotic Circulating Tumor Cells in Early and Metastatic Breast Cancer Patients. Mol Cancer Ther 2013, 12, 1886–1895, doi:https://doi.org/10.1158/1535-7163.mct-12-1167.

    Article  CAS  PubMed  Google Scholar 

  40. Paoletti, C.; Muniz, M.C.; Thomas, D.G.; Griffith, K.A.; Kidwell, K.M.; Tokudome, N.; Brown, M.E.; Aung, K.; Miller, M.C.; Blossom, D.L.; et al. Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor-Positive Breast Cancer. Clin Cancer Res 2015, 21, 2487–98, doi:https://doi.org/10.1158/1078-0432.ccr-14-1913.

    Article  CAS  PubMed  Google Scholar 

  41. Jaeger, B.A.S.; Neugebauer, J.; Andergassen, U.; Melcher, C.; Schochter, F.; Mouarrawy, D.; Ziemendorff, G.; Clemens, M.; Abel, E. v.; Heinrich, G.; et al. The HER2 Phenotype of Circulating Tumor Cells in HER2-Positive Early Breast Cancer: A Translational Research Project of a Prospective Randomized Phase III Trial. Plos One 2017, 12, e0173593, doi:https://doi.org/10.1371/journal.pone.0173593.

  42. Paoletti, C.; Larios, J.M.; Muñiz, M.C.; Aung, K.; Cannell, E.M.; Darga, E.P.; Kidwell, K.M.; Thomas, D.G.; Tokudome, N.; Brown, M.E.; et al. Heterogeneous Estrogen Receptor Expression in Circulating Tumor Cells Suggests Diverse Mechanisms of Fulvestrant Resistance. Mol Oncol 2016, 10, 1078–1085, doi:https://doi.org/10.1016/j.molonc.2016.04.006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Vignot, S.; Besse, B.; André, F.; Spano, J.-P.; Soria, J.-C. Discrepancies between Primary Tumor and Metastasis: A Literature Review on Clinically Established Biomarkers. Crit Rev Oncol Hemat 2012, 84, 301–313, doi:https://doi.org/10.1016/j.critrevonc.2012.05.002.

    Article  Google Scholar 

  44. Powell, A.A.; Talasaz, A.H.; Zhang, H.; Coram, M.A.; Reddy, A.; Deng, G.; Telli, M.L.; Advani, R.H.; Carlson, R.W.; Mollick, J.A.; et al. Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines. Plos One 2012, 7, e33788, doi:https://doi.org/10.1371/journal.pone.0033788.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Sun, Y.-F.; Wu, L.; Liu, S.-P.; Jiang, M.-M.; Hu, B.; Zhou, K.-Q.; Guo, W.; Xu, Y.; Zhong, Y.; Zhou, X.-R.; et al. Dissecting Spatial Heterogeneity and the Immune-Evasion Mechanism of CTCs by Single-Cell RNA-Seq in Hepatocellular Carcinoma. Nat Commun 2021, 12, 4091, doi:https://doi.org/10.1038/s41467-021-24386-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Hurst, D.R.; Edmonds, M.D.; Welch, D.R. Metastamir: The Field of Metastasis-Regulatory MicroRNA Is Spreading. Cancer Res 2009, 69, 7495–7498, doi:https://doi.org/10.1158/0008-5472.can-09-2111.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Tan, K.; Leong, S.M.; Kee, Z.; Caramat, P.V.; Teo, J.; Blanco, M.V.M.; Koay, E.S.C.; Cheong, W.K.; Soh, T.I.-P.; Yong, W.P.; et al. Longitudinal Monitoring Reveals Dynamic Changes in Circulating Tumor Cells (CTCs) and CTC-Associated MiRNAs in Response to Chemotherapy in Metastatic Colorectal Cancer Patients. Cancer Lett 2018, 423, 1–8, doi:https://doi.org/10.1016/j.canlet.2018.02.039.

    Article  CAS  PubMed  Google Scholar 

  48. Reza, K.K.; Dey, S.; Wuethrich, A.; Wang, J.; Behren, A.; Antaw, F.; Wang, Y.; Sina, A.A.I.; Trau, M. In Situ Single Cell Proteomics Reveals Circulating Tumor Cell Heterogeneity during Treatment. Acs Nano 2021, doi:https://doi.org/10.1021/acsnano.0c10008.

  49. Heitzer, E.; Auer, M.; Gasch, C.; Pichler, M.; Ulz, P.; Hoffmann, E.M.; Lax, S.; Waldispuehl-Geigl, J.; Mauermann, O.; Lackner, C.; et al. Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing. Cancer Res 2013, 73, 2965–2975, doi:https://doi.org/10.1158/0008-5472.can-12-4140.

    Article  CAS  PubMed  Google Scholar 

  50. Lyberopoulou, A.; Aravantinos, G.; Efstathopoulos, E.P.; Nikiteas, N.; Bouziotis, P.; Isaakidou, A.; Papalois, A.; Marinos, E.; Gazouli, M. Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue. Plos One 2015, 10, e0123902, doi:https://doi.org/10.1371/journal.pone.0123902.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Kulemann, B.; Rösch, S.; Seifert, S.; Timme, S.; Bronsert, P.; Seifert, G.; Martini, V.; Kuvendjiska, J.; Glatz, T.; Hussung, S.; et al. Pancreatic Cancer: Circulating Tumor Cells and Primary Tumors Show Heterogeneous KRAS Mutations. Sci Rep-uk 2017, 7, 4510, doi:https://doi.org/10.1038/s41598-017-04601-z.

    Article  CAS  Google Scholar 

  52. Chen, Y.; Yang, Z.; Wang, Y.; Wang, J.; Wang, C. Karyotyping of Circulating Tumor Cells for Predicting Chemotherapeutic Sensitivity and Efficacy in Patients with Esophageal Cancer. Bmc Cancer 2019, 19, 651, doi:https://doi.org/10.1186/s12885-019-5850-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Ni, X.; Zhuo, M.; Su, Z.; Duan, J.; Gao, Y.; Wang, Z.; Zong, C.; Bai, H.; Chapman, A.R.; Zhao, J.; et al. Reproducible Copy Number Variation Patterns among Single Circulating Tumor Cells of Lung Cancer Patients. Proc National Acad Sci 2013, 110, 21083–21088, doi:https://doi.org/10.1073/pnas.1320659110.

    Article  CAS  Google Scholar 

  54. Gkountela, S.; Castro-Giner, F.; Szczerba, B.M.; Vetter, M.; Landin, J.; Scherrer, R.; Krol, I.; Scheidmann, M.C.; Beisel, C.; Stirnimann, C.U.; et al. Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding. Cell 2019, 176, 98-112.e14, doi:https://doi.org/10.1016/j.cell.2018.11.046.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Benezeder, T.; Tiran, V.; Treitler, A.A.N.; Suppan, C.; Rossmann, C.; Stoeger, H.; Cote, R.J.; Datar, R.H.; Balic, M.; Dandachi, N. Multigene Methylation Analysis of Enriched Circulating Tumor Cells Associates with Poor Progression-Free Survival in Metastatic Breast Cancer Patients. Oncotarget 2014, 5, 92483–92496, doi:https://doi.org/10.18632/oncotarget.21426.

    Article  Google Scholar 

  56. Papadaki, M.A.; Stoupis, G.; Theodoropoulos, P.A.; Mavroudis, D.; Georgoulias, V.; Agelaki, S. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer. Mol Cancer Ther 2018, 18, molcanther.0584.2018, doi:https://doi.org/10.1158/1535-7163.mct-18-0584.

    Article  CAS  Google Scholar 

  57. Brungs, D.; Minaei, E.; Piper, A.-K.; Perry, J.; Splitt, A.; Carolan, M.; Ryan, S.; Wu, X.J.; Corde, S.; Tehei, M.; et al. Establishment of Novel Long-Term Cultures from EpCAM Positive and Negative Circulating Tumour Cells from Patients with Metastatic Gastroesophageal Cancer. Sci Rep-uk 2020, 10, 539, doi:https://doi.org/10.1038/s41598-019-57164-6.

    Article  CAS  Google Scholar 

  58. Rivera-Baez, L.; Lohse, I.; Lin, E.; Raghavan, S.; Owen, S.; Harouaka, R.; Herman, K.; Mehta, G.; Lawrence, T.S.; Morgan, M.A.; et al. Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine. Cancers 2020, 12, 1011, doi:https://doi.org/10.3390/cancers12041011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Koch, C.; Kuske, A.; Joosse, S.A.; Yigit, G.; Sflomos, G.; Thaler, S.; Smit, D.J.; Werner, S.; Borgmann, K.; Gärtner, S.; et al. Characterization of Circulating Breast Cancer Cells with Tumorigenic and Metastatic Capacity. Embo Mol Med 2020, 12, e11908, doi:https://doi.org/10.15252/emmm.201911908.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Cools-Lartigue, J.; Spicer, J.; McDonald, B.; Gowing, S.; Chow, S.; Giannias, B.; Bourdeau, F.; Kubes, P.; Ferri, L. Neutrophil Extracellular Traps Sequester Circulating Tumor Cells and Promote Metastasis. J Clin Invest 2013, 123, 3446–3458, doi:https://doi.org/10.1172/jci67484.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Sharma, U.; Medina-Saenz, K.; Miller, P.C.; Troness, B.; Spartz, A.; Sandoval-Leon, A.; Parke, D.N.; Seagroves, T.N.; Lippman, M.E.; El-Ashry, D. Heterotypic Clustering of Circulating Tumor Cells and Circulating Cancer-Associated Fibroblasts Facilitates Breast Cancer Metastasis. Breast Cancer Res Tr 2021, 1–18, doi:https://doi.org/10.1007/s10549-021-06299-0.

  62. Ao, Z.; Shah, S.H.; Machlin, L.M.; Parajuli, R.; Miller, P.C.; Rawal, S.; Williams, A.J.; Cote, R.J.; Lippman, M.E.; Datar, R.H.; et al. Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer. Cancer Res 2015, 75, 4681–4687, doi:https://doi.org/10.1158/0008-5472.can-15-1633.

    Article  CAS  PubMed  Google Scholar 

  63. Coffelt, S.B.; Wellenstein, M.D.; Visser, K.E. de Neutrophils in Cancer: Neutral No More. Nat Rev Cancer 2016, 16, 431–446, doi:https://doi.org/10.1038/nrc.2016.52.

    Article  CAS  PubMed  Google Scholar 

  64. Aguirre, L.A.; Montalbán-Hernández, K.; Avendaño-Ortiz, J.; Marín, E.; Lozano, R.; Toledano, V.; Sánchez-Maroto, L.; Terrón, V.; Valentín, J.; Pulido, E.; et al. Tumor Stem Cells Fuse with Monocytes to Form Highly Invasive Tumor-Hybrid Cells. Oncoimmunology 2020, 9, 1773204, doi:https://doi.org/10.1080/2162402x.2020.1773204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Hu, C.-L.; Zhang, Y.-J.; Zhang, X.-F.; Fei, X.; Zhang, H.; Li, C.-G.; Sun, B. 3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma. Oncotargets Ther 2021, Volume 14, 2673–2688, doi:https://doi.org/10.2147/ott.s298427.

    Article  Google Scholar 

  66. Yang, C.; KIM, I.-H.; Chae, H.; Kim, D.-D.; Jeon, C. Detection of Circulating Gastrointestinal Cancer Cells in Conditionally Reprogrammed Cell Culture. In Vivo 2021, 35, 1515–1520, doi:https://doi.org/10.21873/invivo.12404.

  67. Liu, X.; Ory, V.; Chapman, S.; Yuan, H.; Albanese, C.; Kallakury, B.; Timofeeva, O.A.; Nealon, C.; Dakic, A.; Simic, V.; et al. ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells. Am J Pathology 2012, 180, 599–607, doi:https://doi.org/10.1016/j.ajpath.2011.10.036.

    Article  CAS  Google Scholar 

  68. Yang, Y.-P.; Giret, T.M.; Cote, R.J. Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities. Cancers 2021, 13, 2723, doi:https://doi.org/10.3390/cancers13112723.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Suprynowicz, F.A.; Upadhyay, G.; Krawczyk, E.; Kramer, S.C.; Hebert, J.D.; Liu, X.; Yuan, H.; Cheluvaraju, C.; Clapp, P.W.; Boucher, R.C.; et al. Conditionally Reprogrammed Cells Represent a Stem-like State of Adult Epithelial Cells. Proc National Acad Sci 2012, 109, 20035–20040, doi:https://doi.org/10.1073/pnas.1213241109.

    Article  Google Scholar 

  70. Rygaard, J.; Poulsen, C.O. HETEROTRANSPLANTATION OF A HUMAN MALIGNANT TUMOUR TO “NUDE” MICE. Acta Pathologica Microbiol Scand 1969, 77, 758–760, doi:https://doi.org/10.1111/j.1699-0463.1969.tb04520.x.

    Article  CAS  Google Scholar 

  71. Morgan, R.A. Human Tumor Xenografts: The Good, the Bad, and the Ugly. Mol Ther 2012, 20, 882–884, doi:https://doi.org/10.1038/mt.2012.73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Sun, Y.; Xu, Y.; Yang, X.; Guo, W.; Zhang, X.; Qiu, S.; Shi, R.; Hu, B.; Zhou, J.; Fan, J. Circulating Stem Cell–like Epithelial Cell Adhesion Molecule–Positive Tumor Cells Indicate Poor Prognosis of Hepatocellular Carcinoma after Curative Resection. Hepatology 2013, 57, 1458–1468, doi:https://doi.org/10.1002/hep.26151.

    Article  CAS  PubMed  Google Scholar 

  73. Donatis, A.D.; Ranaldi, F.; Cirri, P. Reciprocal Control of Cell Proliferation and Migration. Cell Commun Signal 2010, 8, 20, doi:https://doi.org/10.1186/1478-811x-8-20.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Rossi, E.; Rugge, M.; Facchinetti, A.; Pizzi, M.; Nardo, G.; Barbieri, V.; Manicone, M.; Faveri, S.D.; Scaini, M.C.; Basso, U.; et al. Retaining the Long-Survive Capacity of Circulating Tumor Cells (CTCs) Followed by Xeno-Transplantation: Not Only from Metastatic Cancer of the Breast but Also of Prostate Cancer Patients. Oncoscience 2014, 1, 49–56, doi:https://doi.org/10.18632/oncoscience.8.

    Article  PubMed  Google Scholar 

  75. Hodgkinson, C.L.; Morrow, C.J.; Li, Y.; Metcalf, R.L.; Rothwell, D.G.; Trapani, F.; Polanski, R.; Burt, D.J.; Simpson, K.L.; Morris, K.; et al. Tumorigenicity and Genetic Profiling of Circulating Tumor Cells in Small-Cell Lung Cancer. Nat Med 2014, 20, 897–903, doi:https://doi.org/10.1038/nm.3600.

    Article  CAS  PubMed  Google Scholar 

  76. Morrow, C.J.; Trapani, F.; Metcalf, R.L.; Bertolini, G.; Hodgkinson, C.L.; Khandelwal, G.; Kelly, P.; Galvin, M.; Carter, L.; Simpson, K.L.; et al. Tumourigenic Non-Small-Cell Lung Cancer Mesenchymal Circulating Tumour Cells: A Clinical Case Study. Ann Oncol 2016, 27, 1155–1160, doi:https://doi.org/10.1093/annonc/mdw122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Drapkin, B.J.; George, J.; Christensen, C.L.; Mino-Kenudson, M.; Dries, R.; Sundaresan, T.; Phat, S.; Myers, D.T.; Zhong, J.; Igo, P.; et al. Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts. Cancer Discov 2018, 8, CD-17-0935, doi:https://doi.org/10.1158/2159-8290.cd-17-0935.

    Article  Google Scholar 

  78. Girotti, M.R.; Gremel, G.; Lee, R.; Galvani, E.; Rothwell, D.; Viros, A.; Mandal, A.K.; Lim, K.H.; Saturno, G.; Furney, S.J.; et al. Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma. Cancer Discov 2016, 6, 286–99, doi:https://doi.org/10.1158/2159-8290.cd-15-1336.

    Article  CAS  PubMed  Google Scholar 

  79. Hingorani, A.D.; Kuan, V.; Finan, C.; Kruger, F.A.; Gaulton, A.; Chopade, S.; Sofat, R.; MacAllister, R.J.; Overington, J.P.; Hemingway, H.; et al. Improving the Odds of Drug Development Success through Human Genomics: Modelling Study. Sci Rep-uk 2019, 9, 18911, doi:https://doi.org/10.1038/s41598-019-54849-w.

    Article  CAS  Google Scholar 

  80. Pereira-Veiga, T.; Abreu, M.; Robledo, D.; Matias-Guiu, X.; Santacana, M.; Sanchez, L.; Cueva, J.; Palacios, P.; Abdulkader, I.; Lopez-Lopez, R.; et al. CTCs-Derived Xenograft Development in a Triple Negative Breast Cancer Case. Int J Cancer 2019, 144, 2254–2265, doi:https://doi.org/10.1002/ijc.32001.

    Article  CAS  PubMed  Google Scholar 

  81. Dey, N.; Barwick, B.G.; Moreno, C.S.; Ordanic-Kodani, M.; Chen, Z.; Oprea-Ilies, G.; Tang, W.; Catzavelos, C.; Kerstann, K.F.; Sledge, G.W.; et al. Wnt Signaling in Triple Negative Breast Cancer Is Associated with Metastasis. Bmc Cancer 2013, 13, 537, doi:https://doi.org/10.1186/1471-2407-13-537.

    Article  PubMed  PubMed Central  Google Scholar 

  82. De, P.; Carlson, J.H.; Wu, H.; Marcus, A.; Leyland-Jones, B.; Dey, N. Wnt-Beta-Catenin Pathway Signals Metastasis-Associated Tumor Cell Phenotypes in Triple Negative Breast Cancers. Oncotarget 2016, 7, 43124–43149, doi:https://doi.org/10.18632/oncotarget.8988.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Huang, D.; Huang, Y.; Huang, Z.; Weng, J.; Zhang, S.; Gu, W. Relation of AURKB Over-Expression to Low Survival Rate in BCRA and Reversine-Modulated Aurora B Kinase in Breast Cancer Cell Lines. Cancer Cell Int 2019, 19, 166, doi:https://doi.org/10.1186/s12935-019-0885-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Pitner, M.K.; Taliaferro, J.M.; Dalby, K.N.; Bartholomeusz, C. MELK: A Potential Novel Therapeutic Target for TNBC and Other Aggressive Malignancies. Expert Opin Ther Tar 2017, 21, 849–859, doi:https://doi.org/10.1080/14728222.2017.1363183.

    Article  CAS  Google Scholar 

  85. Vishnoi, M.; Liu, N.H.; Yin, W.; Boral, D.; Scamardo, A.; Hong, D.; Marchetti, D. The Identification of a TNBC Liver Metastasis Gene Signature by Sequential CTC-xenograft Modeling. Mol Oncol 2019, 13, 1913–1926, doi:https://doi.org/10.1002/1878-0261.12533.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Faugeroux, V.; Pailler, E.; Oulhen, M.; Deas, O.; Brulle-Soumare, L.; Hervieu, C.; Marty, V.; Alexandrova, K.; Andree, K.C.; Stoecklein, N.H.; et al. Genetic Characterization of a Unique Neuroendocrine Transdifferentiation Prostate Circulating Tumor Cell-Derived EXplant Model. Nat Commun 2020, 11, 1884, doi:https://doi.org/10.1038/s41467-020-15426-2.

    Article  CAS  Google Scholar 

  87. Najmeh, S.; Cools-Lartigue, J.; Rayes, R.F.; Gowing, S.; Vourtzoumis, P.; Bourdeau, F.; Giannias, B.; Berube, J.; Rousseau, S.; Ferri, L.E.; et al. Neutrophil Extracellular Traps Sequester Circulating Tumor Cells via Β1-integrin Mediated Interactions. Int J Cancer 2017, 140, 2321–2330, doi:https://doi.org/10.1002/ijc.30635.

    Article  CAS  PubMed  Google Scholar 

  88. Shultz, L.D.; Brehm, M.A.; Garcia-Martinez, J.V.; Greiner, D.L. Humanized Mice for Immune System Investigation: Progress, Promise and Challenges. Nat Rev Immunol 2012, 12, 786–798, doi:https://doi.org/10.1038/nri3311.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Minn, A.J.; Gupta, G.P.; Siegel, P.M.; Bos, P.D.; Shu, W.; Giri, D.D.; Viale, A.; Olshen, A.B.; Gerald, W.L.; Massague, J. Genes That Mediate Breast Cancer Metastasis to Lung. Nature 2005, 436, 518–24, doi:https://doi.org/10.1038/nature03799.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Kang, Y.; Siegel, P.M.; Shu, W.; Drobnjak, M.; Kakonen, S.M.; Cordon-Cardo, C.; Guise, T.A.; Massague, J. A Multigenic Program Mediating Breast Cancer Metastasis to Bone. Cancer Cell 2003, 3, 537–49, doi:https://doi.org/10.1016/s1535-6108(03)00132-6.

    Article  CAS  PubMed  Google Scholar 

  91. Ignatiadis, M.; Rack, B.; Rothé, F.; Riethdorf, S.; Decraene, C.; Bonnefoi, H.; Dittrich, C.; Messina, C.; Beauvois, M.; Trapp, E.; et al. Liquid Biopsy-Based Clinical Research in Early Breast Cancer: The EORTC 90091-10093 Treat CTC Trial. Eur J Cancer 2016, 63, 97–104, doi:https://doi.org/10.1016/j.ejca.2016.04.024.

    Article  PubMed  Google Scholar 

  92. Ignatiadis, M.; Litière, S.; Rothe, F.; Riethdorf, S.; Proudhon, C.; Fehm, T.; Aalders, K.; Forstbauer, H.; Fasching, P.A.; Brain, E.; et al. Trastuzumab versus Observation for HER2 Nonamplified Early Breast Cancer with Circulating Tumor Cells (EORTC 90091-10093, BIG 1-12, Treat CTC): A Randomized Phase II Trial. Ann Oncol 2018, 29, 1777–1783, doi:https://doi.org/10.1093/annonc/mdy211.

    Article  CAS  PubMed  Google Scholar 

  93. Stewart, C.A.; Gay, C.M.; Xi, Y.; Sivajothi, S.; Sivakamasundari, V.; Fujimoto, J.; Bolisetty, M.; Hartsfield, P.M.; Balasubramaniyan, V.; Chalishazar, M.D.; et al. Single-Cell Analyses Reveal Increased Intratumoral Heterogeneity after the Onset of Therapy Resistance in Small-Cell Lung Cancer. Nat Cancer 2020, 1, 423–436, doi:https://doi.org/10.1038/s43018-019-0020-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, USA

    Jerry Xiao

  2. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Paula R. Pohlmann

  3. Department of Pathology, Center for Cell Reprogramming, Georgetown University, Washington, DC, USA

    Richard Schlegel & Seema Agarwal

Authors
  1. Jerry Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paula R. Pohlmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Schlegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seema Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seema Agarwal .

Editor information

Editors and Affiliations

  1. Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA

    Richard J. Cote

  2. ACTC Lab, Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Athens, Greece

    Evi Lianidou

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Xiao, J., Pohlmann, P.R., Schlegel, R., Agarwal, S. (2023). State of the Art in the Propagation of Circulating Tumor Cells. In: Cote, R.J., Lianidou, E. (eds) Circulating Tumor Cells. Current Cancer Research. Springer, Cham. https://doi.org/10.1007/978-3-031-22903-9_10

Download citation

Publish with us

Policies and ethics

Search

Navigation